Work Here?
Journey Clinical
Work Here?
Ketamine-assisted psychotherapy with medical oversight
Journey Clinical
Work Here?
Ketamine-assisted psychotherapy with medical oversight
Overview
Journey Clinical offers Ketamine-Assisted Psychotherapy (KAP) for depression, anxiety, and PTSD. It acts as a one-stop treatment partner where a medical consultation leads to ketamine prescription, administration, and accompanying psychotherapy in a coordinated care plan. The approach blends ketamine's effects with structured psychotherapy to tackle symptoms from multiple angles under medical oversight. The company stands out with a patient-centered, collaborative care model and a team of MDs, PhDs, and licensed clinicians delivering personalized, accessible therapy.
About Journey Clinical
Industries
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$11.5M
Headquarters
New York City, null
Founded
2020
Get referred to Journey Clinical
See people who can refer or advise you
Simplify's Take
What believers are saying
- DEA telemedicine flexibilities stay open through December 31, 2026, supporting remote ketamine prescribing.
- Journey Clinical says major insurers cover KAP, and patients receive reimbursement in 30 states.
- The 2026 White House executive order boosts psychedelic medicine attention and future access pathways.
What critics are saying
- DEA telemedicine relief expires December 31, 2026; tighter rules would break its remote workflow.
- Georgia's 2026 ketamine-clinic law signals state licensing, ownership, and staffing scrutiny spreading nationwide.
- FDA ketamine safety warnings and compounding crackdowns threaten prescriber confidence, referrals, and Journey Clinical's existential market.
What makes Journey Clinical unique
- Journey Clinical runs therapist-led KAP with in-network prescribers across 30 states.
- It claims the largest U.S. psychedelic-assisted psychotherapy provider network, anchored by thousands of therapists.
- Its model keeps therapists independent while Journey Clinical handles medical oversight and prescribing.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$11.5M
Below
Industry Average
Funded Over
2 Rounds
Industry standards
Benefits
Flexible Work Hours
Remote Work Options
Training Programs
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↑ 0%2 year growth
↑ 3%For those curious to learn more, The Juniper Center has partnered with Journey Clinical - a platform that connects therapists with licensed prescribers and offers research and resources on KAP for both clients and providers.
Gateway to Solutions, a trusted provider of ketamine-assisted psychotherapy for eight years, has recently partnered with Journey Clinical for a seamless and collaborative KAP experience.
Compass Pathways plc (Nasdaq: CMPS) entered into a research collaboration agreement this week with Journey Clinical, a U.S.-based psychedelic-assisted psychotherapy platform.
This October, Journey Clinical launched a partnership with the Integrative Psychiatry Institute (IPI) to support their students and graduates in becoming successful Ketamine-Assisted Psychotherapy providers.
Journey Clinical partnered up with Fluence to offer some training and then they also needed professional resource in order to grow their practice.
Journey Clinical is Hiring for 14 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Journey Clinical
Industries
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$11.5M
Headquarters
New York City, null
Founded
2020
Journey Clinical is Hiring for 14 Jobs on Simplify!
Find jobs on Simplify and start your career today